Medacist Solutions Group LLC  

Cheshire,  CT 
United States
  • Booth: 1571


Medacist Solutions Group is the lead innovator in drug diversion analytics as evidenced by being granted the only U.S. patent for drug diversion. Our core initiative is to deliver actionable information focused on the medication use process to drive better patient safety outcomes for the clients we serve.

Medacist has been the leader in drug diversion analytics since its inception. Over the past 20 years, we’ve supported thousands of hospitals across the country with our RxAuditor analytics suite. As both the healthcare and technology fields evolve, Medacist is transforming alongside them. Come visit us at booth 1571 to learn more about our industry exclusive innovation in diversion analytics!


  • RxAuditor Investigate
    The innovation of RxAuditor Investigate was born from the need to curate a list of “at-risk” individuals from a larger list of statistically identified diversion outliers....

  • The previous need to perform time-consuming manual audits is eliminated by the incorporation of autonomous diversion auditing through evaluation, scoring, and ranking of risk - thus reducing false positives and curating a targeted list of “at-risk” individuals. 

    RxAuditor Investigate’s main objective is to target risk within the medication-use-process and identify areas of risk across your organization at any level of responsibility - with a single glance, while providing a start-to-finish auditing portal for all members of a diversion risk team.

    RxAuditor Investigate’s Key Features

    • Target individual regions, hospitals, care areas, and outliers by risk score
    • Evaluate diversion incidents enterprise wide
    • Document evidence and provide feedback for each outlier’s investigation
    • Collaborate with members of the drug diversion team using a workflow management portal
    • Decide collectively for each outlier – justify, confirm, or watch activity.